Security key
G8807B106
Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH)
CUSIP: G8807B106
Q2 2020 13F Holders as of 30 Jun 2020
- Security type / class
- Equity / Ordinary Share $0.00001 Par Value
- Total 13F shares
- 52,961,450
- Total 13F value
- $1,111,646,885
- Share change
- -3,890,076
- SEC-reported price per share
- $20.99
- Number of holders
- 121
- Value change
- -$95,003,651
- Number of buys
- 74
- Number of sells
- 37
- Shares outstanding
- 51,428,000
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2020
Institutions
121
Top holders
10
TBPH full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2020
Previous quarter: Q1 2020
Theravance Biopharma, Inc. SEC filings
Theravance Biopharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP G8807B106
Recent filing periods:
Ownership snapshot
Top reported holders of TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
31 Mar 2020
13F
Lead comparable stake: 18%
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 18%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
18%
BAUPOST GROUP LLC/MA
18%
BlackRock Finance, Inc.
17%
Link Fund Solutions Ltd
9.4%
VANGUARD GROUP INC
8.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
18%
|
$216,436,000
9,365,444 shares
|
— | 31 Mar 2020 |
| BAUPOST GROUP LLC/MA |
13F
Company
|
18%
|
$215,135,000
9,309,168 shares
|
— | 31 Mar 2020 |
| BlackRock Finance, Inc. |
13F
Company
|
17%
|
$202,923,000
8,780,790 shares
|
— | 31 Mar 2020 |
| Link Fund Solutions Ltd |
13F
Company
|
9.4%
|
$111,296,000
4,836,864 shares
|
— | 31 Mar 2020 |
| VANGUARD GROUP INC |
13F
Company
|
8.6%
|
$102,448,000
4,433,056 shares
|
— | 31 Mar 2020 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
8.1%
|
$96,312,000
4,167,523 shares
|
— | 31 Mar 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
121
Shares
52,961,450
Rows available
121
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
102
Q2 2020 holders
121
Holder diff
19
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 value | Q2 2020 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend